[Therapeutic study with metabolit 8 of bromhexine in deficiency of alveoli surface-active substance].
D000336:Aerosols; D000818:Animals; D001964:Bromhexine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D005260:Female; D005333:Fetus / Q000187:drug effects; D006651:Histocytochemistry; D008168:Lung / Q000166:cytology / Q000187:drug effects; D051379:Mice; D011247:Pregnancy; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000378:metabolism*; D011817:Rabbits; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000336:Aerosols; D011663:Pulmonary Surfactants; D013501:Surface-Active Agents; D001964:Bromhexine
Therapeutische Untersuchungen mit Metabolit 8 von Bromhexin bei mangelhafter oberflächenaktiver Substanz der Alveolen